Corient Capital Partners, LLC Pfizer Inc Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 116,005 shares of PFE stock, worth $3.44 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

116,005

Previous 116,005 -0.0%

Holding current value

$3.44 Million

Previous $6.08 Million -0.0%

% of portfolio

0.46%

Previous 0.46%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $731,218 - $866,996	15,715 Added 15.67%	116,005 $6.08 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $408,456 - $506,128	8,928 Added 9.77%	100,290 $5.19 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $176,890 - $262,211	4,281 Added 4.92%	91,362 $5.4 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $174,034 - $223,562	4,434 Added 5.36%	87,081 $3.75 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $232,768 - $263,687	6,482 Added 8.51%	82,647 $3.24 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $272,809 - $307,674	-8,146 Reduced 9.66%	76,165 $2.76 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $15,931 - $20,258	476 Added 0.57%	84,311 $3.1 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $271,113 - $318,077	8,539 Added 11.34%	83,835 $3.08 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $814,324 - $987,895	-27,036 Reduced 26.42%	75,296 $2.46 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $348,200 - $497,502	-12,882 Reduced 11.18%	102,332 $3.34 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $64,753 - $73,487	-1,967 Reduced 1.68%	115,214 $4.51 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $701,751 - $909,965	21,599 Added 22.6%	117,181 $4.21 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $418,243 - $469,591	11,310 Added 13.42%	95,582 $4.14 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $55,200 - $60,646	1,472 Added 1.78%	84,272 $3.58 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $799,637 - $911,673	20,786 Added 33.52%	82,800 $3.61 Million
Q2 2018 Oct 02, 2018	BUY	$32.98 - $35.16 $774,436 - $825,627	23,482 Added 60.94%	62,014 $2.25 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $4,084 - $4,738	-128 Reduced 0.33%	38,532 $1.37 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $95,955 - $101,811	2,885 Added 8.06%	38,660 $1.4 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $190,464 - $209,817	-6,144 Reduced 14.66%	35,775 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,961 Added 4.91%	41,919 $1.41 Million
Q1 2017 Aug 17, 2017	SELL	N/A	-83,535 Reduced 67.64%	39,958 $1.37 Million
Q1 2017 Aug 14, 2017	BUY	N/A	123,493	123,493 $5.17 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Pfizer Inc Transaction History